Sionna Therapeutics hopes to raise $150 million and secure a market capitalization of about $692 million in an initial public ...

Eleva, a German biopharmaceutical company, and 3PBIOVIAN, a global contract development and manufacturing organization (CDMO) ...

French drugmaker Mitem Pharma, which is dedicated to drugs of major therapeutic interest (DMTI), today revealed that has ...

Russia is experiencing a sharp growth in the demand for drugs against diabetes this year, particular those that are also used ...

US President Donald Trump has implemented a series of tariffs on imports from Canada, Mexico and China, but the additional ...

Japan’s ASKA Pharmaceutical Holdings announced it has decided to acquire additional shares of Vietnam-based Ha Tay ...

A Feature on M&A, VC investment licensing and partnerships focusing on novel targets in autoimmune diseases. The global ...

I-Mab has laid off almost a third of its employees as part of a restructuring effort, the company disclosed in a recent ...

Chinese biotech company Vigonvita Life Sciences has filed for an initial public offering (IPO) on the Hong Kong Stock ...

The company earlier announced that the primary endpoint was met in a randomized, double-blind, placebo-controlled Phase IIb ...

US mRNA specialist Moderna demonstrated substantial R&D investment and progress in the UK, two years since signing its ...

The market for Parkinson’s disease (PD) drugs across the seven major geographies (7MM; USA, France, Germany, Italy, UK and ...